GlobeNewswire Inc.··Kahn Swick & Foti, LlcImmunityBio Stock Crashes 21% After FDA Warning on Cancer Drug Marketing
ImmunityBio faces securities fraud lawsuit following FDA warning letter about Anktiva cancer therapy misleading ads. Stock plummeted to $7.42.
IBRXsecurities fraudclass action lawsuit